Announced Thu, 16 Jul · 18:26 IST
Brooks Labs signs binding MoU for partial BSL stake sale, expects INR 106.33 cr
Strategic Transactions View source PDF
BROOKS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.8%1-day move
₹70.00
prior close
₹71.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0—+0.0—-2.8-4.7-5.7-5.7-8.6—————
Up moveDown movePending
AI summary
Brooks Laboratories signed a binding MoU with Steriscience Specialties and its JV Brooks Steriscience Limited (BSL) regarding a partial stake sale. Brooks holds 49% in BSL, which will drop to 32.67% post-deal. The transaction is expected to bring about INR 106.33 crores for growth and expansion. The two-year MoU includes a value protection framework ensuring the retained 32.67% stake is valued at not less than USD 22.87 million, based on an agreed USD 70 million business value.
Likely market impact
Partial stake sale unlocks about INR 106.33 cr cash for expansion; value protection secures retained 32.67% investment.